You are here

  • Home
  • Archive
  • Volume 23, Issue 7
  • Alterations of Hypoxia-Induced Factor Signaling Pathway Due to Mammalian Target of Rapamycin (mTOR) Suppression in Ovarian Clear Cell Adenocarcinoma: In Vivo and in Vitro Explorations for Clinical Trial

Article info

Article menu
Download PDFPDF
Ovarian Cancer
Alterations of Hypoxia-Induced Factor Signaling Pathway Due to Mammalian Target of Rapamycin (mTOR) Suppression in Ovarian Clear Cell Adenocarcinoma: In Vivo and in Vitro Explorations for Clinical Trial

Authors

  1. Address correspondence and reprint requests to Masanori Yasuda, MD, PhD, Department of Pathology, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka, Saitama 350-1298, Japan. E-mail: m_yasuda{at}saitama-med.ac.jp.

Citation

Hirasawa T, Miyazawa M, Yasuda M, et al
Alterations of Hypoxia-Induced Factor Signaling Pathway Due to Mammalian Target of Rapamycin (mTOR) Suppression in Ovarian Clear Cell Adenocarcinoma: In Vivo and in Vitro Explorations for Clinical Trial
International Journal of Gynecologic Cancer 2013;23:1210-1218.

Publication history

  • Received February 6, 2013
  • Accepted May 22, 2013
  • First published September 1, 2013.
Online issue publication 
June 18, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2013 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.